Chidamide Combination With Lenalidomide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
NCT04329130
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Relapsed or Refractory Peripheral T-cell Lymphoma
Interventions
DRUG:
Chidamide, Lenalidomide
Sponsor
Sun Yat-sen University